The Rot Begins at the Top
My assessment of healthcare in 2026: while “individualized precision medicine” – predictive, preventive, personalized and participatory (4P medicine) – is hailed as the future, its real-world implementation faces significant structural obstacles in a system where strict guidelines given to practitioners mainly revolve around a band-aid-like approach to an ailment.
Humans are creatures – and preachers – of habit. Physicians are time-constrained, and most of them have adopted practice patterns they are unwilling to change to adapt to the new methodology of prescribing personalised precision medicines based on an individual’s lifestyle, biology, and environment.
Now consider this: if lying benefits the liar, liars multiply. Several pharma companies and researchers have already been caught fabricating or manipulating data. So the uncomfortable question is: what percentage of the data coming out is true? How does a physician know the veracity of this data – and if he doesn’t know, how does he make an informed decision in his practice? The answer to this is that we need more philanthropy-driven research.
It’s said - 70% and upwards of those authors who write guidelines for statins and PCSK9 inhibitors have some kind of a bias due to vested interests in the companies that manufacture them. Unless this deception is removed, we will continue to pump medicines and adopt procedures instead of following the new path of personalised precision medicines in sync with a mindful lifestyle approach.
Zareer Patell
#Healthcare #PrecisionMedicine #LifestyleMedicine #PreventiveHealth #MedicalEthics #BigPharma #PersonalizedMedicine #Wellness #Medicine
Comments